LY-450108

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLY-450108
Drug Alias NameLY 503430LY-450108LY-2607540
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA modulators
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsCognition DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A